Recent Finacing
Recent Raise
ABL Bio is a Seoul-based biotechnology company developing bispecific antibodies and related ADC therapies through its proprietary Grabody platform.
Focus Areas
Recent Investors
Total Raised
Funding round
See the team members at ABL Bio.
